CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 43 enrolled
Drug / intervention
Oral supplementation of vitamin Ddietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01781169
NCT01781169N/ACompleted
CompareCT.gov

Health Effect of Oral Vitamin D Supplementation on Obese Chinese Males

Shenzhen Center for Chronic Disease Control·interventional·Posted Jan 31, 2013·Updated Oct 30, 2013

In Brief

A clinical study evaluating Oral supplementation of vitamin D for Obesity and Insulin Resistance. Completed, enrolled 43 participants across 1 site.

Detailed Summary

Hypothesis: Oral Supplementation of Vitamin D can Reduce Hypersecretion of Parathyroid Hormone and Insulin Resistance in Obese Chinese Males. Protocol: Weekly oral supplementation of 50,000 IU vitamin D (cholecalciferol) or eight weeks to the obese males compared with the normal-weight males. Index measures were conducted at baseline and endpoint.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Insulin Resistance
CountriesChina
CollaboratorsDanone Institute China Diet Nutrition Research and Communication

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 31, 2013
Enrollment StartApr 1, 2011
Primary CompletionDec 1, 2011
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 13.4 years ago

Interventions

Oral supplementation of vitamin Ddietary

Weekly oral supplementation of 50,000 IU vitamin D (cholecalciferol) for eight weeks to the obese males compared with the normal-weight males. The chemical form of vitamin D is cholecalciferol capsuled as fine powder.